Generic Fosamax Plus D
Even though the first patents for Fosamax Plus D (alendronate and cholecalciferol) have expired, there are currently no generic versions available. This could be because a later-expiring patent is protecting it from generic competition. It is important to note that alendronate and cholecalciferol is the generic name for Fosamax Plus D and is not a generic version of it.
Fosamax Plus D™ (alendronate and cholecalciferol) is a prescription medication used for osteoporosis. It is part of a group of medications known as bisphosphonates.
Fosamax Plus D is made by Merck & Co., Inc. It is currently under the protection of a patent that prevents any generic Fosamax Plus D from being manufactured in the United States.
The first patents for Fosamax Plus D have already expired. However, no generic versions are available. This suggests that other patents, set to expire later, are still protecting the drug from generic competition. The next Fosamax Plus D patent is set to expire in January 2019. This is the earliest predictable date that a generic version of the drug could become available.
However, other circumstances could come up to extend or shorten the exclusivity period. This could include such things as other patents for specific Fosamax Plus D uses or lawsuits. There have already been several lawsuits examining the issue of Fosamax patents, and more lawsuits are likely to occur. Once the patents expire and any lawsuits are resolved, several companies will likely begin manufacturing generic Fosamax Plus D.
No -- alendronate and cholecalciferol are the active ingredients in Fosamax Plus D, but they are not a generic version of it. What can be confusing is that, oftentimes, the active ingredient of any drug is referred to as the "generic name." The generic name is different from a generic version of a medicine. In order for there to be a generic version of a medicine, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.